Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration

  • Albrecht LommatzschEmail author


Age-related macular degeneration (AMD) is the most common cause of blindness defined by law, in the western world, its late stages having a reported frequency of 12% [1]. It is a complex disease of the central retina with a prevalence of 30% in the population aged over 80 years.


  1. 1.
    Bressler NM, Bressler SB. Preventative ophthalmology. Age-related macular degeneration. Ophthalmology. 1995;102:1206–11.CrossRefPubMedGoogle Scholar
  2. 2.
    Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–74.CrossRefPubMedGoogle Scholar
  3. 3.
    Green WR, Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993;100:1519–35.CrossRefPubMedGoogle Scholar
  4. 4.
    Pauleikhoff D, Loffert D, Spital G, et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol. 2002;240:533–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Bird AC, Marshall J. Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc U K. 1986;105(Pt 6):674–82.PubMedGoogle Scholar
  6. 6.
    Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol. 1985;69:397–403.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48:257–93.CrossRefPubMedGoogle Scholar
  8. 8.
    Schrader WF. [Age-related macular degeneration: a socioeconomic time bomb in our aging society]. Ophthalmologe. 2006;103:742–8.Google Scholar
  9. 9.
    Pauleikhoff D, Scheider A, Wiedmann P, et al. Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications. Ophthalmologe. 2009;106(3):242–51. doi: 10.1007/s00347-008-1797-9.
  10. 10.
    Wong TY, Chakravarthy U, Klein R, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008;115:116–26.CrossRefPubMedGoogle Scholar
  11. 11.
    Arroyo JG, Yang L, Bula D, Chen DF. Photoreceptor apoptosis in human retinal detachment. Am J Ophthalmol. 2005;139:605–10.CrossRefPubMedGoogle Scholar
  12. 12.
    Chang CJ, Lai WW, Edward DP, Tso MO. Apoptotic photoreceptor cell death after traumatic retinal detachment in humans. Arch Ophthalmol. 1995;113:880–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Green WR, Key III. SN. Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc. 1977;75:180–254.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Okubo A, Rosa Jr RH, Bunce CV, et al. The relationships of age changes in retinal pigment epithelium and Bruch’s membrane. Invest Ophthalmol Vis Sci. 1999;40:443–9.PubMedGoogle Scholar
  15. 15.
    Bairati Jr A, Orzalesi N. The ultrastructure of the pigment epithelium and of the photoreceptor-pigment epithelium junction in the human retina. J Ultrastruct Res. 1963;41:484–96.CrossRefPubMedGoogle Scholar
  16. 16.
    Nakaizumi Y, Hogan MJ, Feeney L. The ultrastructure of Bruch’s membrane. 3. The macular area of the human eye. Arch Ophthalmol. 1964;72:395–400.CrossRefPubMedGoogle Scholar
  17. 17.
    Lommatzsch A, Hermans P, Muller KD, et al. Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch Clin Exp Ophthalmol. 2008;246:803–10.CrossRefPubMedGoogle Scholar
  18. 18.
    Davis WL, Jones RG, Hagler HK. An electron microscopic histochemical and analytical X-ray microprobe study of calcification in Bruch’s membrane from human eyes. J Histochem Cytochem. 1981;29:601–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Guymer R, Luthert P, Bird A. Changes in Bruch’s membrane and related structures with age. Prog Retin Eye Res. 1999;18:59–90.CrossRefPubMedGoogle Scholar
  20. 20.
    Kunze A, Abari E, Semkova I, Paulsson M, Hartmann U. Deposition of nidogens and other basement membrane proteins in the young and aging mouse retina. Ophthalmic Res. 2010;43:108–12.CrossRefPubMedGoogle Scholar
  21. 21.
    Gass JD. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol. 1984;68:513–9.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Barondes MJ, Pagliarini S, Chisholm IH, Hamilton AM, Bird AC. Controlled trial of laser photocoagulation of pigment epithelial detachments in the elderly: 4 year review. Br J Ophthalmol. 1992;76:5–7.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845–81.CrossRefPubMedGoogle Scholar
  24. 24.
    Bird AC. Doyne Lecture. Pathogenesis of retinal pigment epithelial detachment in the elderly; the relevance of Bruch’s membrane change. Eye (Lond). 1991;5(Pt 1):1–12.CrossRefGoogle Scholar
  25. 25.
    Mouallem A, Sarraf D, Chen X, et al. Double retinal pigment epithelium tears in neovascular age-related macular degeneration. Retina. 2016;36:2197–204.CrossRefPubMedGoogle Scholar
  26. 26.
    Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–34.CrossRefPubMedGoogle Scholar
  27. 27.
    Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990;10:1–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Gamulescu MA, Helbig H, Wachtlin J. [Differential diagnosis and therapy of pigment epithelial detachment]. Ophthalmologe. 2014;111:79–90; quiz 91–2.Google Scholar
  29. 29.
    Hartnett ME, Weiter JJ, Garsd A, Jalkh AE. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol. 1992;230:11–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Zayit-Soudry S, Moroz I, Loewenstein A. Retinal pigment epithelial detachment. Surv Ophthalmol. 2007;52:227–43.CrossRefPubMedGoogle Scholar
  31. 31.
    Pauleikhoff D, Koch JM. Prevalence of age-related macular degeneration. Curr Opin Ophthalmol. 1995;6:51–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Baumal CR, Reichel E, Duker JS, Wong J, Puliafito CA. Indocyanine green hyperfluorescence associated with serous retinal pigment epithelial detachment in age-related macular degeneration. Ophthalmology. 1997;104:761–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Yannuzzi LA, Wong DW, Sforzolini BS, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol. 1999;117:1503–10.CrossRefPubMedGoogle Scholar
  34. 34.
    Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009;147:644–52.CrossRefPubMedGoogle Scholar
  35. 35.
    Lehmann B, Heimes B, Gutfleisch M, et al. [Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE]. Ophthalmologe. 2015;112:49–56.Google Scholar
  36. 36.
    Cukras C, Agron E, Klein ML, et al. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: age-related eye disease study report no. 28. Ophthalmology. 2010;117:489–99.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439–52.CrossRefPubMedCentralGoogle Scholar
  38. 38.
    Chan CK, Lin SG. Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment. Eur J Ophthalmol. 2007;17:674–6.PubMedGoogle Scholar
  39. 39.
    Chan CK, Meyer CH, Gross JG, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina. 2007;27:541–51.CrossRefPubMedGoogle Scholar
  40. 40.
    Bartels S, Barrelmann A, Book B, et al. [Tear in retinal pigment epithelium under anti-VEGF therapy for exudative age-related macular degeneration : function recovery under intensive therapy]. Ophthalmologe. 2014;111:460–4.Google Scholar
  41. 41.
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. 2010;248:5–11.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of OphthalmologySt. Franziskus HospitalMuensterGermany
  2. 2.Department of OphthalmologyUniversity of Duisburg-EssenEssenGermany

Personalised recommendations